Cambridge Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.92M |
| 2 |
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
|
+$1.71M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.3M |
| 4 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$1.26M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$990K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.42M |
| 2 |
ARK Genomic Revolution ETF
ARKG
|
+$1.04M |
| 3 |
CERN
Cerner Corp
CERN
|
+$953K |
| 4 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$902K |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$752K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.98% |
| 2 | Healthcare | 6.4% |
| 3 | Industrials | 2.64% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 1.67% |
Similar funds
Cambridge Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Cambridge Advisors held 191 positions worth $366M, down 13% from $420M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Cambridge Advisors's Q2 2022 filing shows 12 new, 48 increased, 94 reduced and 14 closed positions. Its largest new stake was First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF: 110,151 shares worth $1.47M. The largest sale was Vanguard Total Bond Market, an estimated $2.42M.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9% a quarter earlier, followed by Healthcare and Industrials.
- Cambridge Advisors's largest Q2 2022 buy was First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF: 110,151 shares worth $1.47M.
- Cambridge Advisors added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $1.92M increase.
- Cambridge Advisors's biggest Q2 2022 reduction was Vanguard Total Bond Market, cutting an estimated $2.42M.
- Cambridge Advisors fully exited ARK Genomic Revolution ETF in Q2 2022, selling an estimated $1.04M.
- Cambridge Advisors's ten largest holdings make up 55% of its $366M portfolio in Q2 2022.
- Cambridge Advisors opened 12 new positions and closed 14 in Q2 2022.
- Cambridge Advisors's portfolio value fell 13% quarter-over-quarter to $366M.
Based on Cambridge Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.